Prosol 20% sulfite free in plastic container
Clinical Indications
Concentrated amino acid source for compounding Total Parenteral Nutrition (TPN) admixtures. Used to meet high protein requirements in severe catabolic states or fluid restriction.
Dosing & Administration Rate
Rarely infused alone. Compounded with dextrose, lipids, and electrolytes by pharmacy.
Warnings & Precautions
Contraindicated in severe hepatic coma or severe metabolic abnormalities involving amino acids. Monitor BUN and ammonia.
Contraindications
Known hypersensitivity to amino acids. Severe liver disease or hepatic coma. Severe renal impairment (without dialysis). Abnormalities of amino acid metabolism.
Pharmacology & Safety Profile
Mechanism of Action
Provides a source of biologically utilizable essential and non-essential amino acids for protein synthesis, and dextrose as a source of calories.
Adverse Reactions
Phlebitis, fluid overload, hyperglycemia, hyperosmolar syndrome, electrolyte imbalances, metabolic acidosis, liver enzyme elevations.
Compatibility Notes
Used as base for pharmacy compounding.
Electrolyte & Composition Profile
| Component | Amount / Concentration |
|---|---|
| Essential & Non-Essential Amino Acids | 200 g/L (20%) |
| Water for Injection | q.s. |
| Caloric Density | 800 kcal/L (from protein) |
| Nitrogen Content | 32 g/L |
Clinical Parameters
Clinical Disclaimer: Data compiled from FDA DailyMed, Baxter/Fresenius prescribing information, and USP monographs. Always verify against the physical product label, your institution's IV protocols, and current pharmacist guidance before administration.
Related IV Solutions in Parenteral Nutrition